Search by Drug Name or NDC

    NDC 15370-0170-99 RELAFEN DS 1000 mg/1 Details

    RELAFEN DS 1000 mg/1

    RELAFEN DS is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Carwin Pharmaceutical Associates, LLC. The primary component is NABUMETONE.

    Product Information

    NDC 15370-0170
    Product ID 15370-170_48aa3640-1dd2-4693-9b0d-a99595b97a0e
    Associated GPIs 66100055000340
    GCN Sequence Number 041308
    GCN Sequence Number Description nabumetone TABLET 1000 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 94457
    HICL Sequence Number 006311
    HICL Sequence Number Description NABUMETONE
    Brand/Generic Brand
    Proprietary Name RELAFEN DS
    Proprietary Name Suffix n/a
    Non-Proprietary Name NABUMETONE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 1000
    Active Ingredient Units mg/1
    Substance Name NABUMETONE
    Labeler Name Carwin Pharmaceutical Associates, LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203166
    Listing Certified Through 2025-12-31

    Package

    NDC 15370-0170-99 (15370017099)

    NDC Package Code 15370-170-99
    Billing NDC 15370017099
    Package 1 BLISTER PACK in 1 CARTON (15370-170-99) / 2 TABLET in 1 BLISTER PACK
    Marketing Start Date 2020-02-28
    NDC Exclude Flag N
    Pricing Information N/A